The former MD of the PPMC, Suleiman Achimugu, died in the early hours of Monday morning from the novel coronavirus, Leakblast has learnt.
He is the first casualty of COVID-19 in Nigeria.
In a statement by the Nigeria Centre for Disease Control (NCDC):
“The case was a 67-year-old male who returned home following medical treatment in UK.
“He had underlying medical conditions- multiple myeloma & diabetes & was undergoing chemotherapy
“Our thoughts are with his family.”
RELATED NEWS: Water crucial to COVID-19 fight, says WHO
Achimugu is said to have arrived in Nigeria from the UK two weeks ago. He reportedly started showing symptoms of the disease on Tuesday.
His family are said to have reported to the NCDC soon after, with the health authorities coming to the house to take a blood sample.
They never got back to the family.
As of Sunday afternoon, the former PPMC MD was coughing profusely, and the NCDC was called to inquire about his results.
The result was positive.
He was picked up and rushed to the hospital at Gwagwalada, FCT.
Watch Leakblast TV channel from around the world
Achimugu died at 2 am Monday morning. His family are currently under quarantine in their house. The NCDC will handle the burial.
If you are happy to be contacted by a Leakblast journalist please leave a telephone number that we can contact you on. In some cases a selection of your comments will be published, displaying your name as you provide it and location, unless you state otherwise. Your contact details will never be published. When sending us pictures, video or eyewitness accounts (CLICK HERE) ,at no time should you endanger yourself or others, take any unnecessary risks or infringe any laws.
SUPPORT LEAKBLAST JOURNALISM OF INTEGRITY AND CREDIBILITY
Good journalism costs a lot of money.
For continued free access to the best investigative journalism in the country we ask you to consider making a modest support to this noble Endeavor.
By contributing to LeakBlast, you are helping to sustain a journalism of relevance and ensuring it remains free and available to all.